<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-9190</journal-id>
<journal-title><![CDATA[Revista alergia México]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. alerg. Méx.]]></abbrev-journal-title>
<issn>2448-9190</issn>
<publisher>
<publisher-name><![CDATA[Colegio Mexicano de Inmunología Clínica y Alergia A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-91902024000400229</article-id>
<article-id pub-id-type="doi">10.29262/ram.v71i4.1306</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Prevalencia de bronquiectasias en pacientes con errores innatos de la inmunidad]]></article-title>
<article-title xml:lang="en"><![CDATA[Prevalence of bronchiectasis in patients with inborn errors of immunity]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Korkowski-Uviña]]></surname>
<given-names><![CDATA[Karla]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gómez-Hernández]]></surname>
<given-names><![CDATA[Noemí]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Quintero-Ramos]]></surname>
<given-names><![CDATA[Antonio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Contreras-Rodríguez]]></surname>
<given-names><![CDATA[Felipe de J.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ortega-Cisneros]]></surname>
<given-names><![CDATA[Margarita]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Especialidades Centro Médico Nacional de Occidente]]></institution>
<addr-line><![CDATA[Guadalajara, Jalisco ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Especialidades Centro Médico Nacional de Occidente]]></institution>
<addr-line><![CDATA[Guadalajara, Jalisco ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Especialidades Centro Médico Nacional de Occidente]]></institution>
<addr-line><![CDATA[Guadalajara, Jalisco ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Especialidades Centro Médico Nacional de Occidente]]></institution>
<addr-line><![CDATA[Guadalajara, Jalisco ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Hospital de Especialidades Centro Médico Nacional de Occidente]]></institution>
<addr-line><![CDATA[Guadalajara, Jalisco ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2024</year>
</pub-date>
<volume>71</volume>
<numero>4</numero>
<fpage>229</fpage>
<lpage>233</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-91902024000400229&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-91902024000400229&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-91902024000400229&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivos: Establecer la prevalencia de bronquiectasias, correlacionar la dosis de inmunoglobulina IgG por vía intravenosa o subcutánea y estimar las concentraciones de IgG sérica con el puntaje total de la escala de Bhalla y la gravedad de las bronquiectasias, además de asociar los valores de IgG sérica con los procesos infecciosos pulmonares en pacientes con diagnóstico de errores innatos de la inmunidad.  Métodos: Estudio descriptivo, observacional y transversal, llevado a cabo en pacientes mayores de 18 años con diagnóstico de errores innatos de la inmunidad. Se revisaron los expedientes clínicos y las tomografías computadas de cada caso.  Resultados: Se registraron 38 pacientes con diagnóstico de errores innatos de la inmunidad. La prevalencia de bronquiectasia fue del 36.8%. Respecto a la correlación de los procesos infecciosos pulmonares con concentraciones de IgG sérica, se encontró diferencia en los pacientes entre los años 2020 y 2022 (p = 0.002, 0.054 y 0.030, respectivamente). Al efectuar la correlación de severidad de bronquiectasias, el puntaje total de escala de Bhalla, las dosis de inmunoglobulina IgG (intravenosa o subcutánea) y las concentraciones séricas de IgG, mediante la prueba Rho de Spearman, se encontró significación estadística.  Conclusión: Es importante solicitar estudios de tomografía de tórax cada 3 a 4 años en pacientes con errores innatos de la inmunidad para detectar oportunamente bronquiectasias, instaurar un tratamiento temprano y mejorar la calidad de vida y las tasas de supervivencia de los pacientes, y con ello disminuir los costos hospitalarios.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective: To establish the prevalence of bronchiectasis, correlate the IgG IV or SC immunoglobulin dose and serum IgG levels with the total Bhalla score and the severity of bronchiectasis and associate serum IgG levels with the development of pulmonary infectious processes in patients with diagnosis of innate errors of immunity.  Methods: A descriptive, observational, cross-sectional study with patients over 18 years of age diagnosed with IBD. Clinical records and computed axial tomography were reviewed.  Results: 38 patients with IBD were included, where the prevalence of bronchiectasis was 36.8%. (Regarding the correlation of pulmonary infectious processes with serum IgG levels, a difference was found in patients from 2020 to 2022 (p= 0.002, 0.054, 0.030 respectively). The correlation of severity of bronchiectasis, total score of Bhalla scale, IgG IV or SC immunoglobulin dose and serum IgG levels by Spearman's Rho test I were found to be significantly correlated.  Conclusion: It is important to perform chest tomography studies every 3-4 years in patients with IBD to detect timely bronchiectasis, initiate treatment in time, improving patients' quality of life and survival rates, and reducing hospital costs.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Bronquiectasias]]></kwd>
<kwd lng="es"><![CDATA[IgG]]></kwd>
<kwd lng="es"><![CDATA[Escala de Bhalla]]></kwd>
<kwd lng="es"><![CDATA[Errores innatos de la inmunidad]]></kwd>
<kwd lng="es"><![CDATA[Calidad de vida]]></kwd>
<kwd lng="en"><![CDATA[Bronchiectasis]]></kwd>
<kwd lng="en"><![CDATA[IgG]]></kwd>
<kwd lng="en"><![CDATA[Bhalla score]]></kwd>
<kwd lng="en"><![CDATA[Inborn errors of immunity]]></kwd>
<kwd lng="en"><![CDATA[Quality of life]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bonilla]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ballas]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Practice parameter for the diagnosis and management of primary immunodeficiency]]></article-title>
<source><![CDATA[J Allergy Clin Inmmunol]]></source>
<year>2015</year>
<volume>136</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1186-205.e1-78</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hill]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sullivan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chalmers]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[British Thoracic Society Guideline for bronchiectasis in adults]]></article-title>
<source><![CDATA[Thorax]]></source>
<year>2018</year>
<volume>74</volume>
<page-range>1-69</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Imam]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Non-CF bronchiectasis: Orphan disease no longer]]></article-title>
<source><![CDATA[Resp Med]]></source>
<year>2020</year>
<volume>166</volume>
<page-range>105940</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Velásquez-Ortiz María]]></surname>
<given-names><![CDATA[Guadalupe]]></given-names>
</name>
<name>
<surname><![CDATA[Patricia María]]></surname>
<given-names><![CDATA[O'Farrill-Romanillos]]></given-names>
</name>
<name>
<surname><![CDATA[Laura]]></surname>
<given-names><![CDATA[Berrón-Ruiz]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Conceptos generales de las inmunodeficiencias humorales]]></article-title>
<source><![CDATA[Rev Alergia Méx]]></source>
<year>2020</year>
<volume>67</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>142-64</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chalmers]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hill]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis]]></article-title>
<source><![CDATA[Moll Inmmunol]]></source>
<year>2013</year>
<volume>55</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>27-34</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lonni]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chalmers]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Goeminne]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Etiology of Non-Cystic Fibrosis Bronchiectasis in Adults and Its Correlation to Disease Severity]]></article-title>
<source><![CDATA[Ann Am Thorac Soc]]></source>
<year>2015</year>
<volume>12</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1764-70</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chalmers]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Goeminne]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Aliberti]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Derivation and validation of the bronchiectasis severity index: an international multicentre observational study]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2014</year>
<volume>189</volume>
<page-range>576-85</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bhalla]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Turcios]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Aponte]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cystic fibrosis: scoring system with thin-section CT]]></article-title>
<source><![CDATA[Radiology]]></source>
<year>1991</year>
<volume>179</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>783-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vivas-Rosales]]></surname>
<given-names><![CDATA[IJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Ojeda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[O'Farrill-Romanillos]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera-Sánchez]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Severidad de bronquiectasias en pacientes adultos con inmunodeficiencia común variable]]></article-title>
<source><![CDATA[Rev Alergia Méx]]></source>
<year>2018</year>
<volume>65</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>242-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández-Ojeda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vivas-Rosales]]></surname>
<given-names><![CDATA[IJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza-Reyna]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
<name>
<surname><![CDATA[Múzquiz-Zermeño]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tipo y localización de bronquiectasias en una cohorte de adultos con inmunodeficiencia común variable]]></article-title>
<source><![CDATA[Rev Méd IMSS]]></source>
<year>2017</year>
<volume>55</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>414-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[King]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The pathophysiology of bronchiectasis]]></article-title>
<source><![CDATA[Int J Chron Obstruct Pulmon Dis]]></source>
<year>2009</year>
<volume>4</volume>
<page-range>411-9</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mogica]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[VR]]></given-names>
</name>
<name>
<surname><![CDATA[Montaño]]></surname>
<given-names><![CDATA[VB]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neumopatías en pacientes con inmunodeficiencias primarias en tratamiento con gammaglobulina intravenosa]]></article-title>
<source><![CDATA[Rev Alerg Mex]]></source>
<year>2007</year>
<volume>54</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>14-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cunningham-Rundles]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How I treat common variable immune deficiency]]></article-title>
<source><![CDATA[Blood]]></source>
<year>2010</year>
<volume>116</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>7-15</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wall]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Wisner]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
<name>
<surname><![CDATA[Gipson]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Sorensen]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bronchiectasis in Primary Antibody Deficiencies: A Multidisciplinary Approach]]></article-title>
<source><![CDATA[Front Immunol]]></source>
<year>2020</year>
<volume>11</volume>
<page-range>522</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
